Exhibit 99.1


           CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
            PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Health Express USA, Inc. on Form
10-QSB for the quarter ended September 29, 2002, as filed with the Securities
and Exchange Commission on the date hereof, I, Douglas R. Baker, the Chief
Executive Officer and Acting Chief Financial Officer of the Company, certify,
pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002, that:

1. I have reviewed this quarterly report on Form 10-QSB of Health Express USA,
Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary in
order; to make the statements made, in light of the circumstances under which
such statements were made not, not misleading;

3. Based on my knowledge, the financial statements and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations of the registrant as of,
and for, the periods presented in this quarterly report;

4. I am responsible for establishing and maintaining internal controls and have:

         a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its consolidated
subsidiaries is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

         b) evaluated the effectiveness of the registrant's internal controls
and procedures as of a date within 90 days prior to this quarterly report (the
"Evaluation Date"); and

         c) presented in this quarterly report our conclusions about the
effectiveness of our internal controls based on our evaluation as of the
Evaluation Date;

5. I have disclosed to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent function):

         a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weakness in internal controls; and

         b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
controls; and

6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

Date: November 15, 2002                      /s/ Douglas R. Baker
                                            ----------------------------------
                                            Name: Douglas R. Baker
                                            Title: Chief Executive Officer and
                                            Acting Chief Financial Officer